We are live on ! Find out more
YTEN

Yield10 Bioscience, Inc. Common Stock
YTEN

Delisted

YTEN was delisted on the 15th of May, 2024.

Back to rankings

5 hedge funds and large institutions have $753K invested in Yield10 Bioscience, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

76% more capital invested

Capital invested by funds: $427K → $753K (+$326K)

29% less funds holding

Funds holding: 7 → 5 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
5
Holders Change
-2
Holders Change %
-28.57%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$18K
2
Morgan Stanley
Morgan Stanley
New York
-$1.09K
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
1
Cannell & Co
New York
$333K – – –
BlackRock
2
BlackRock
New York
$236K – – –
BC
3
Birchview Capital
Vermont
$118K – – –
VF
4
Virtu Financial
New York
$64K +$58.2K +427 New
HDIM
5
Hanson & Doremus Investment Management
Vermont
$2K – – –
UBS Group
6
UBS Group
Switzerland
– -$18K -132 Closed
Morgan Stanley
7
Morgan Stanley
New York
– -$1.09K -8 Closed

YTEN Hedge Fund Activity: Q2 2020 in Review

5 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q2 2020, worth a combined $753K — up 76% from $427K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of YTEN and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was UBS Group, exiting entirely with an estimated $18K sold.

  • 5 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q2 2020, down from 7 in Q1 2020.
  • Funds reported $753K of Yield10 Bioscience, Inc. Common Stock stock for Q2 2020, up 76% quarter-over-quarter.
  • 1 fund opened new Yield10 Bioscience, Inc. Common Stock positions in Q2 2020 and 3 closed out, a net change of -2 holders.
  • The largest Yield10 Bioscience, Inc. Common Stock seller in Q2 2020 was UBS Group, an estimated $18K sold.

Based on aggregated 13F filings for Q2 2020.